Related references
Note: Only part of the references are listed.Jumping into the future: overcoming pharmacokinetic/pharmacodynamic hurdles to optimize the treatment of severe difficult to treat-Gram-negative infections with novel beta-lactams
Milo Gatti et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2023)
Real-world, Multicenter Experience With Meropenem-Vaborbactam for Gram-Negative Bacterial Infections Including Carbapenem-Resistant Enterobacterales and Pseudomonas aeruginosa
Sara Alosaimy et al.
OPEN FORUM INFECTIOUS DISEASES (2021)
Meropenem-Vaborbactam versus Ceftazidime-Avibactam for Treatment of Carbapenem-Resistant Enterobacteriaceae Infections
Renee Ackley et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2020)
Real-world Multicenter Analysis of Clinical Outcomes and Safety of Meropenem-Vaborbactam in Patients Treated for Serious Gram-Negative Bacterial Infections
Sara Alosaimy et al.
OPEN FORUM INFECTIOUS DISEASES (2020)
Meropenem/vaborbactam: a next generation β-lactam β-lactamase inhibitor combination
Andrea Novelli et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2020)
Ultra-performance liquid chromatography-tandem mass spectrometric method for quantitation of the recently Food and Drug Administration approved combination of vaborbactam and meropenem in human plasma
Ahmed K. Kammoun et al.
ROYAL SOCIETY OPEN SCIENCE (2020)
Development of an HPLC Method for the Determination of Meropenem/Vaborbactam in Biological and Aqueous Matrixes
Christina A. Sutherland et al.
JOURNAL OF CHROMATOGRAPHIC SCIENCE (2020)
A validated LC-MSMS method for the simultaneous quantification of meropenem and vaborbactam in human plasma and renal replacement therapy effluent and its application to a pharmacokinetic study
Suzanne L. Parker et al.
ANALYTICAL AND BIOANALYTICAL CHEMISTRY (2019)
Phase 1 Study of the Safety, Tolerability, and Pharmacokinetics of Vaborbactam and Meropenem Alone and in Combination following Single and Multiple Doses in Healthy Adult Subjects
Christopher M. Rubino et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
Simultaneous quantification of cefepime, meropenem, ciprofloxacin, moxifloxacin, linezolid and piperacillin in human serum using an isotope-dilution HPLC-MS/MS method
M. Paal et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2018)
Meropenem-vaborbactam for the treatment of complicated urinary tract infections including acute pyelonephritis
Gary Wu et al.
EXPERT OPINION ON PHARMACOTHERAPY (2018)
Simultaneous determination of nine β-lactam antibiotics in human plasma by an ultrafast hydrophilic-interaction chromatography-tandem mass spectrometry
Alan Abdulla et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2017)
Determination of meropenem levels in human serum by high-performance liquid chromatography with ultraviolet detection
Thomas Roth et al.
BIOMEDICAL CHROMATOGRAPHY (2017)
Quantification of piperacillin, tazobactam, cefepime, meropenem, ciprofloxacin and linezolid in serum using an isotope dilution UHPLC-MS/MS method with semi-automated sample preparation
Johannes Zander et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2015)
Ultrafast quantification of β-lactam antibiotics in human plasma using UPLC-MS/MS
Mieke Carlier et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2015)
Measurement of meropenem concentration in different human biological fluids by ultra-performance liquid chromatography-tandem mass spectrometry
Rauel Rigo-Bonnin et al.
ANALYTICAL AND BIOANALYTICAL CHEMISTRY (2014)
Rapid quantification of six β-lactams to optimize dosage regimens in severely septic patients
Fleur Wolff et al.
TALANTA (2013)
A method for determining the free (unbound) concentration of ten beta-lactam antibiotics in human plasma using high performance liquid chromatography with ultraviolet detection
Scott E. Briscoe et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2012)
Share Paper
